Key result
Overexpression of Notch3 significantly reduced myocardial fibrosis area compared to control (14.62% vs 38.58%, p<0.001) in a rat model of myocardial infarction by inhibiting the RhoA/ROCK/Hif1α signaling pathway.
Why the study?
The role of Hif1alpha in Notch3-regulated cardiac fibroblast function under normoxia remained unclear.
Absolute Event Rate: 14.62% vs 38.58%
p-value: p=<0.001
Notch3 overexpression attenuates cardiac fibrosis and improves left ventricular function post-myocardial infarction in rats by negatively regulating the RhoA/ROCK/Hif1α axis.
Hypothesis-generating for Notch3 in normoxic cardiac fibroblasts; leaves open therapeutic targeting in heart failure.
Cardiac fibrosis is a common pathophysiological process of heart failure development for multiple cardiovascular diseases. The abnormality of cardiac fibroblast(CF) function is the key event of cardiac fibrosis. Notch signaling pathway and Hif1α was reported to be involved in several pathogenic processes including cardiac fibrosis under hypoxia.The role of Hif1α in Notch3-regulated CF function under normoxia remain unclear. The present study was designed to determinethe effect of Notch3 on CF function and its relation with Hif1α. First, we demonstrated that Notch3 inhibited cell proliferation, prevented cardiac fibroblast to myofibroblast transition and promoted apoptosis in CFs.The knockdown of Notch3 had the exact opposite effect. Next, we found Notch3 regulated CF function by negative regulation of RhoA/ROCK/Hif1α signal pathway under normoxia. Finally, extending CF-based studies to rat MI-model, overexpression of Notch3 by the Ad-N3ICD injection alleviated the elevation of RhoA, ROCK1, ROCK2 and Hif1α in MI and further prevented MI induced cardiac fibrosis. Based on these results, we conclude that Notch3 is involved in CF proliferation, apoptosis, and fibroblast to myofibroblast transition by negative regulation of RhoA/ROCK/Hif1α axis independent of hypoxia. These findings are significant to further understand the pathogenesis of cardiac fibrosis and provide new ideas for future treatment.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2020) studied Cardiac fibrosis and Myocardial infarction. Notch3 overexpression (Ad-N3ICD) vs. Ad-GFP (control vector) was evaluated on Myocardial fibrosis area (p=<0.001). Overexpression of Notch3 significantly reduced myocardial fibrosis area compared to control (14.62% vs 38.58%, p<0.001) in a rat model of myocardial infarction by inhibiting the RhoA/ROCK/Hif1α signaling pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: